Comparable to primary tumor cell lines, CRISPR/Cas9 knock-out of PDGFRβ in ALK+ cells (Fig. S2B) also led to a decrease in proliferation when seeded at a low cell density (Fig. 2B). The gene discussed is PDGFRB; the disease is neoplasm.